AU2002363367A1 - Use of endothelin receptor antagonists in the treatment of tumour diseases - Google Patents

Use of endothelin receptor antagonists in the treatment of tumour diseases

Info

Publication number
AU2002363367A1
AU2002363367A1 AU2002363367A AU2002363367A AU2002363367A1 AU 2002363367 A1 AU2002363367 A1 AU 2002363367A1 AU 2002363367 A AU2002363367 A AU 2002363367A AU 2002363367 A AU2002363367 A AU 2002363367A AU 2002363367 A1 AU2002363367 A1 AU 2002363367A1
Authority
AU
Australia
Prior art keywords
treatment
receptor antagonists
endothelin receptor
tumour diseases
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002363367A
Inventor
Christiane Amendt
Dieter Dorsch
Matthias Grell
Werner Mederski
Mathias Osswald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2002363367A1 publication Critical patent/AU2002363367A1/en
Abandoned legal-status Critical Current

Links

AU2002363367A 2001-11-09 2002-10-10 Use of endothelin receptor antagonists in the treatment of tumour diseases Abandoned AU2002363367A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10155076.6 2001-11-09

Publications (1)

Publication Number Publication Date
AU2002363367A1 true AU2002363367A1 (en) 2003-05-19

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003261100A1 (en) Devices delivering therapeutic agents and methods regarding the same
PL398596A1 (en) Preparation containing human antibodies for the treatment of disorders associated with TNF-α
PL374118A1 (en) Interleukin-1 receptors in the treatment of diseases
AU2003299747A1 (en) Tumor killing/tumor regression using cxcr4 antagonists
PL369822A1 (en) Use of endothelin receptor antagonists in the treatment of tumour diseases
AU2003216592A8 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
IL164463A (en) Use of osteoprotegerin in the preparation of medicaments
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003279841A1 (en) Uses of human zven antagonists
PL375561A1 (en) Therapeutic use
AU2003250831A1 (en) Use of hec1 antagonists in the treatment of proliferative disorders and cancer
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003236649A1 (en) Egf receptor antagonists in the treatment of gastric cancer
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003238057A1 (en) Human receptor tyrosine kinase mertk
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2002363367A1 (en) Use of endothelin receptor antagonists in the treatment of tumour diseases
GB0201025D0 (en) The treatment of degenerative diseases
AU2003240446A1 (en) Use of mob-5 in pain
AU2002344959A1 (en) Use of fasl for the treatment of neurodegenerative diseases
GB0128122D0 (en) Therapeutic use
AU2003245995A1 (en) Use of gaba-c receptor antagonists for the treatment of myopia
AU2002365654A1 (en) Treatment of diseases via the skin
AU2002357468A1 (en) Use of 2-acylindoles in the treatment of tumors